Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

CHU - Hôpitaux de Rouen Company Profile

19:13 EDT 23rd April 2014 | BioPortfolio

Nil

Location

1 rue de Germont
Rouen
76031
France

Contact

Phone: 02 32 88 89 90
Email: maitre-toile@chu-rouen.fr


News Articles [9 Associated News Articles listed on BioPortfolio]

Ariana Pharma : trois nouveaux projets lancés en 2013 pour des solutions personnalisées contre le cancer

Ariana Pharma, société spécialiste de l’analyse des données cliniques et des tests diagnostiques pour la médecine personnalisée, vient d’annoncer le lancement du projet ExtempoRMN. A travers...

Regain d’intérêt pour le potentiel thérapeutique des ARN, publication dans The Lancet des résultats de la première thérapie génique européenne de la maladie de Parkinson..

♦ Nouveaux accords pour des médicaments basés sur l’ARN. Les utilisations thérapeutiques de l’ARN sont au cœur d’une série d’accords importants intervenus depuis le début de l’année...

GSK investit dans la science et dans la production – Une carte européenne de la nanomédecine …

♦ GSK investit dans la science et dans la production. Le groupe pharmaceutique GSK vient de créer le consortium OCTC (Oncology Clinical and Translational Consortium), qui regroupe six centres de r...

Deglutition Disorders Global Clinical Trials Review, H2, 2013

Recently added to the BioPortfolio report store, Deglutition Disorders Global Clinical Trials Review, H2, 2013 is a new report from GlobalData published on 2013-12-29. This 53-page report is availabl...

Gastrointestinal Hemorrhage Global Clinical Trials Review, H2, 2013

Recently added to the BioPortfolio report store, Gastrointestinal Hemorrhage Global Clinical Trials Review, H2, 2013 is a new report from GlobalData published on 2013-12-29. This 70-page report is av...

Pheochromocytoma Global Clinical Trials Review, H1, 2014

Recently added to the BioPortfolio report store, Pheochromocytoma Global Clinical Trials Review, H1, 2014 is a new report from GlobalData published on 2014-03-30. This 82-page report is available in...

Dermatomyositis Global Clinical Trials Review, H1, 2014

Recently added to the BioPortfolio report store, Dermatomyositis Global Clinical Trials Review, H1, 2014 is a new report from GlobalData published on 2014-02-18. This 75-page report is available in P...

Expert Medical Mediator and Coordinator from France Added to the Leading Physicians of the World

As one of the leading general practitioners and medical mediators of France, Jan-Cedric Hansen, MD, PhD, has been selected to represent his community in the publication of The Leading Physicians of th...

Drugs and Medications [0 Results]

None

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Corrigendum.

D'Souza RN, Dunnvald M, Frazier-Bowers S, Polverini PJ, Wright JT, de Rouen T, Vieira AR (2013). Translational genetics: Advancing fronts for craniofacial health. J Dent Res 92:1058-1064. (Original DO...

Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir.

Background. The majority of patients receiving the platinum-based chemotherapy drug oxaliplatin develop peripheral neurotoxicity. Because this neurotoxicity involves ROS production, we investigated th...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Effects of Substance P Antagonists on Adrenal Secretion

Data from the literature and previous in vitro research conducted in the investigators' laboratory (INSERM U413/EA4310, University of Rouen) suggest that adrenal corticosteroid secretion m...

Biological Efficacy of Clopidogrel After Implantation of Drug-Eluting Stents (SPACE)

The risk of thrombotic complications after implantation of drug-eluting stents (DES) may be increased in patients with diabetes mellitus (DM) or metabolic syndrome (MS). It is recommended...

CYTRAM (Cytochrome P450, Tramadol)

Many methods to detect CYP2D6 poor metabolizers have been validated. Some of them are based on phenotyping (metabolism of dextromethorphan or debrisoquine) and some others on genotyping. U...

Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence

Fecal incontinence is a major public health issue since 10% of the French population aged 45 has to deal with it. Different treatments exist and have already been evaluated, like the sacra...

Companies [8 Associated Companies listed on BioPortfolio]

CHU - Hôpitaux de Rouen

Nil

Normandie Développement Rouen

An Internationally Renowned French and European Region! 3.2 million inhabitants, 5th biggest French economic region, 2nd largest region for industrial investments per capita, Number one French port c...

Université de Rouen

NIL

PROTEOMIC SOLUTIONS

Founded in 2001, PROTEOMIC SOLUTIONS is a specialized protein lab service located between Paris and Rouen that conducts proteomic projects and practices recombinant protein technology, combined with e...

ANGANY Genetics

ANGANY Genetics is a biotechnology company specialising in the development and production of high quality recombinant allergens for the diagnosis and treatment of allergies. This...

More Information about "CHU - Hôpitaux de Rouen" on BioPortfolio

We have published hundreds of CHU - Hôpitaux de Rouen news stories on BioPortfolio along with dozens of CHU - Hôpitaux de Rouen Clinical Trials and PubMed Articles about CHU - Hôpitaux de Rouen for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CHU - Hôpitaux de Rouen Companies in our database. You can also find out about relevant CHU - Hôpitaux de Rouen Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement